Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust

News   Apr 05, 2017 | Original story from Enterprise Therapeutics

 
Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust
 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

Piglets Might Unlock Keys to IVF in Humans

News

During an attempt to improve how they grow stem cells, researchers discovered a method that uses a special liquid medium and improves the success of IVF in pigs.

READ MORE

BioAscent Announces New CEO and Plans to Expand Discovery Services Offering

News

BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE